Projects per year
Personal profile
Biography
|
Natalie obtained her Ph.D from the University of Melbourne, Department of Microbiology and Immunology in 2003. Following this she was a post-doc at the Department of Biochemistry and Molecular Biology at Monash University, and now pursues her own research vision as a laboratory head within the same department. Natalie has received prestigious fellowships including an NHMRC Peter Doherty fellowship, an NHMRC Career Development Award, a L'Oreal for Women in Science Fellowship and an ARC Future Fellowship. |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- antiviral immunity
- ubiquitination
- host:pathogen interactions
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Keystone Symposia Conference - Innate Immunity: Signaling Mechanisms. Keystone, Colorado February 2008
Borg, N. (Primary Chief Investigator (PCI))
Project: Research
-
Characterisation of the TRIM25-Zap interaction and influence of RNA
Borg, N. (Primary Chief Investigator (PCI)), Neil, S. (Chief Investigator (CI)) & Swanson, C. (Chief Investigator (CI))
Monash University – Internal Faculty Contribution
20/11/18 → 19/11/19
Project: Research
-
Novel HTS platform to identify specific antiviral and anticancer agents
Borg, N. (Primary Chief Investigator (PCI)) & Jans, D. (Chief Investigator (CI))
20/06/18 → 31/12/18
Project: Research
-
Beckman Coulter Optima Analytical Ultracentrifuge (AUC)
Dunstone, M. (Primary Chief Investigator (PCI)), Whisstock, J. (Chief Investigator (CI)), Daly, R. (Chief Investigator (CI)), Atkinson, S. (Chief Investigator (CI)), Turner, S. (Chief Investigator (CI)), Lithgow, T. (Chief Investigator (CI)), Gras, S. (Chief Investigator (CI)), Stone, M. (Chief Investigator (CI)), Davidovich, C. (Chief Investigator (CI)), Rood, J. (Chief Investigator (CI)), Coulibaly, F. (Chief Investigator (CI)), Wilce, J. (Chief Investigator (CI)), Borg, N. (Chief Investigator (CI)), McGowan, S. (Chief Investigator (CI)), Buckle, A. (Chief Investigator (CI)), Elmlund, D. (Chief Investigator (CI)), Elmlund, H. (Chief Investigator (CI)), Belousoff, M. (Chief Investigator (CI)), Ellisdon, A. (Chief Investigator (CI)), Law, R. (Chief Investigator (CI)), Purcell, A. (Chief Investigator (CI)), Cryle, M. (Chief Investigator (CI)), Nold, M. (Chief Investigator (CI)), Nold, C. (Chief Investigator (CI)), Warr, C. (Chief Investigator (CI)), Johnson, T. (Chief Investigator (CI)), Henstridge, M. (Chief Investigator (CI)), Aguilar, M. (Chief Investigator (CI)), Stroud, D. (Chief Investigator (CI)) & Ryan, M. (Chief Investigator (CI))
1/12/16 → 31/12/17
Project: Research
-
Structural studies towards the development of Hendra virus inhibitors
Borg, N. (Primary Chief Investigator (PCI))
ANZ Executors and Trustee Company Ltd.
1/01/14 → 31/12/14
Project: Research
-
DExD/H-box helicases in HIV-1 replication and their inhibition
Heaton, S. M., Gorry, P. R. & Borg, N. A., Apr 2023, In: Trends in Microbiology. 31, 4, p. 393-404 12 p.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access14 Citations (Scopus) -
The multifaceted roles of NLRP3-modulating proteins in virus infection
Harris, J. & Borg, N. A., 30 Aug 2022, In: Frontiers in Immunology. 13, 16 p., 987453.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access22 Citations (Scopus) -
Active site metals mediate an oligomeric equilibrium in Plasmodium M17 aminopeptidases
Malcolm, T. R., Belousoff, M. J., Venugopal, H., Borg, N. A., Drinkwater, N., Atkinson, S. C. & McGowan, S., Jan 2021, In: Journal of Biological Chemistry. 296, 15 p., 100173.Research output: Contribution to journal › Article › Research › peer-review
Open Access8 Citations (Scopus) -
Trim25 and dead‐box rna helicase ddx3x cooperate to regulate rig‐i‐mediated antiviral immunity
Atkinson, S. C., Heaton, S. M., Audsley, M. D., Kleifeld, O. & Borg, N. A., 2 Aug 2021, In: International Journal of Molecular Sciences. 22, 16, 20 p.Research output: Contribution to journal › Article › Research › peer-review
18 Citations (Scopus) -
RK-33 Is a Broad-Spectrum Antiviral Agent That Targets DEAD-Box RNA Helicase DDX3X
Yang, S. N. Y., Atkinson, S. C., Audsley, M. D., Heaton, S. M., Jans, D. A. & Borg, N. A., 9 Jan 2020, In: Cells. 9, 1, 13 p., 170.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile36 Citations (Scopus)
Prizes
-
Accepted into The Bridge Program (QUT)
Borg, N. (Recipient), 2018
Prize: Prize (including medals and awards)
-
-
-
-
BDI industry engagement funding for The Bridge Program
Borg, N. (Recipient), 2018
Prize: Prize (including medals and awards)
-
16th Melbourne Protein Group (MPG) Student Symposium, Keynote Speaker
Borg, N. (Keynote/plenary speaker)
2017 → …Activity: Participating in or organising an event types › Contribution to conference
-
L'Oreal for Women in Science Mentoring Scheme, mentor
Borg, N. (Contributor)
2017 → …Activity: Community Talks, Presentations, Exhibitions and Events › Public outreach
-
Wellcome Trust, peer reviewer (Event)
Borg, N. (Peer reviewer)
2017 → …Activity: Publication peer-review and editorial work types › Peer review responsibility
-
Health Research Council (HRC) of New Zealand, peer reviewer (Event)
Borg, N. (Peer reviewer)
7 Dec 2016 → 20 Feb 2017Activity: Publication peer-review and editorial work types › Peer review responsibility
-
The University of Alaska’s IDeA Network of Biomedical Research Excellence, peer reviewer (Event)
Borg, N. (Peer reviewer)
2016 → …Activity: Publication peer-review and editorial work types › Peer review responsibility
Press/Media
-
Australian researchers make key malaria breathroughs
21/06/15
1 Media contribution
Press/Media: Research
-
Young Maltese-Australian scientist fighting viruses and cancer
19/04/09
1 Media contribution
Press/Media: Research
-